Armata Pharmaceuticals appoints Dr. Daniel Gilmer to Nominating and Corporate Governance Committee

Armata Pharmaceuticals, Inc.

Dr. Daniel Gilmer appointed to the Nominating and Corporate Governance Committee effective June 24, 2026.
Committee cash retainer set at $5,000, pro-rated from effective date.
Amendment to April 24, 2026 8-K that reported his board appointment.

item 5.02

Armata Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-077313

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.